CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 180 enrolled
Drug / intervention
50 Micrograms Vaginal Misoprostol (Intervention) +1 moredrug
Likely dose
50 Micrograms Vaginal Misoprostol (Intervention)from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05262738
NCT05262738Phase 4Completed
CompareCT.gov

Misoprostol Dosing in BMI Greater Than 30: A Randomized Controlled Trial

University of Texas at Austin·interventional·Posted Mar 2, 2022·Updated Jul 3, 2024

In Brief

A Phase 4 clinical trial evaluating 50 Micrograms Vaginal Misoprostol (Intervention) and 25 Micrograms Vaginal Misoprostol (Control) for Pregnancy Related and 2 related conditions. Completed, enrolled 180 participants across 1 site.

Detailed Summary

The investigators are performing a randomized controlled-trial investigating if 50mcg (compared to 25 mcg) of vaginal misoprostol reduces the time from induction start to delivery in obese women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPregnancy Related, Obesity, Labor Onset and Length Abnormalities
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2023202420252026
First PostedMar 2, 2022
Enrollment StartJun 1, 2022
Primary CompletionJul 14, 2023
Study CompletionJul 17, 2023
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 4.3 years ago

Interventions

50 Micrograms Vaginal Misoprostol (Intervention)drug

Subjects will undergo cervical ripening with 50 micrograms of vaginal misoprostol every 4 hours.

25 Micrograms Vaginal Misoprostol (Control)drug

Subjects will undergo cervical ripening with 25 micrograms of vaginal misoprostol every 4 hours.